Saulius Cicenas

Vilnius, VL, Lithuania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Lung cancer screening in Lithuania: a cost-effectiveness analysis.

Lung cancer screening in Lithuania: a cost-effectiveness analysis.

Journal: Journal of comparative effectiveness research

Published: July 16, 2026

Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.

Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.

Journal: Molecular oncology

Published: March 23, 2026

How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 12, 2025

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 10, 2025

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.

Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab.

Journal: Frontiers in oncology

Published: August 07, 2025

Urban-rural residence location and cancer-specific mortality among colorectal, lung and ovarian cancer patients: a nationwide retrospective cohort study from Lithuania.

Urban-rural residence location and cancer-specific mortality among colorectal, lung and ovarian cancer patients: a nationwide retrospective cohort study from Lithuania.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 09, 2025

Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet.

Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 06, 2025

Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer Patients.

Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer Patients.

Journal: OncoTargets and therapy

Published: April 26, 2024

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.

Journal: BMC cancer

Published: April 03, 2024

Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients.

Comparison of targeted next generation sequencing assays in non-small cell lung cancer patients.

Journal: Discover oncology

Published: March 27, 2024

Detection of Oncogene Hotspot Mutations in Female NSCLC Tumor DNA and Cell-Free DNA.

Detection of Oncogene Hotspot Mutations in Female NSCLC Tumor DNA and Cell-Free DNA.

Journal: Cancers

Published: March 07, 2024

Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study.

Evaluation of antihypertensive medications use and survival in patients with ovarian cancer: a population-based retrospective cohort study.

Journal: BMC women's health

Published: October 05, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026